s y s t o l i c HP, B.P. varying between 140-200 rmn Hg. Glucagon stimu l a t i o n caused paradoximal hypoglycemia.
Light and e l e c t r o n microscopy of l i v e r biopsy were c o n s i s t e n t with GSD. Enzyme a s s a y s (courtesy of Dr. G. Hug) revealed t h e following: C6-PI--t a s e 5.6 u moles P/min/g t i s s u e (N = 4.7 + 1.9); l i v e r and musc l e debrancher enzyme was p r e s e n t ; l i v e r phosphorylase was 12.0 u moles P/min/g t i s s u e (N = 25.1 + 6 . 5 ) ; a c t i v e muscle phosphory l a s e was 9.71 (N = 47.7 + 13.2) and t o t a l muscle phosphorylase was 53.5 (N = 78.0 + 21.1); l i v e r phosphorylase kinase was 0.067 n moles b---+a/min/mg ? r o t . (N = 0.175 f 0.068). Catecholamine s , VMA, HVA, 17-OH, 17-KS. Aldosterone, plasma renin. Ccr, IVP, Johns Hopkins University School of Medicine, can significantly increase the height of patients with IUGR. In o r d e r to determine whether the initial increase in growth r a t e shown by Foley (J. Pediatr. 84: 635, 1974) is sustained through subsequent treatment. 1 9 p e p u b e a IUGR patients (term gestation, height ~4 3 . 7 cm, weight <2kg) were treated with hGH. Ten of them received a second treatment Growth r a t e s in cm/year were 4.8 + 1.4 (mean + SD) f o r the pretreatment period (mean duration 14 months), 7.6 2 2.3 for the f i r s t treatment period (mean 13. 7 months), 4.2 / 2.5 f o r the interval between treatments (mean ll. 1 months), 5.9 + 1.4 for the second treatment period (mean 13. 7 months) and 4.3 + 2.6 f o r the post-treatment (mean 13.6 months). Growth r a t e s for the two treatment significantly g r e a t e r than the pre-, interval between, and nt rates. The SD below the mean in height increased between the onset of treatment and the most recent meaixteen untreated IUGR patients followed f o r 2 5 y e a r s did reasing growth r a t e s in children with IUGR, although the magnitude ailability of hGH, therapy appears to be A 9 2/12 male with McCune-Albright Syndrome and acromegaly length-178cm) had continued e l e v a t i o n of growth hormone(GH) and r o l a c t i n ( P r ) d e s p i t e surgery and r a d i a t i o n f o r a P i t u i t a r y Adeoma a t 7 11/12 y r s . He p e r s p i r e d f r e e l y and c o n s t a n t l y needed a r g e r shoes. H i s continued r a p i d g r o w t h (~l 0 c m l y r ) and s e v e r e i b r o u s d y s p l a s i a led t o r e c u r r e n t p a t h o l o g i c a l f r a c t u r e s of h i s emurs. A 5 mo. t r i a l of CB-154 was i n i t i a t e d . The r e s u l t s of e q u e n t i a l r e s t i n g GH and P r concentrations and an o r a l glucose o l e r a n c e t e s t (OGTT) were:
Schneider, V i r g i n i a V. Weldon, Ehud Ben-Galim and GH(n /ml) P r ( n /ml) 
In t h e syndrome of f a m i l i a l dwarfism with high plasma immunor e a c t i v e growth hormone (GH)(Laron Syndrome), elevated l e v e l s of GH a r e a s s o c i a t e d with low l e v e l s of plasma somatomedin t h a t do not i n c r e a s e following a d m i n i s t r a t i o n of GH.
These p a t i e n t s do not respond t o treatment with GH.
The two s u b j e c t s of t h i s r e p o r t were three-year-old boys with dwarfism (height ages 1 3/12 and 1 6/12 y e a r s ) and delayed bone ages ( 1 3/12 and 1 9/12 y e a r s ) . Both had normal GH response a f t e r s t i m u l a t i o n a s s o c i a t e d with undetectable l e v e l s of somatomedin. However, u n l i k e p a t i e n t s with Laron Syndrome, t h e two p a t i e n t s generated normal l e v e l s of somatomedin a f t e r i n t r amuscular a d m i n i s t r a t i o n of GH.
Treatment with GH (2 I U every o t h e r day) brought a s i g n i f i c a n t i n c r e a s e i n t h e growth r a t e of both p a t i e n t s .
The growth r a t e of t h e f i r s t p a t i e n t increased from 2 cmlyear b e f o r e treatment, t o 16 cm/year on therapy. The growth r a t e of t h e second p a t i e n t was 4.5 cmlyear b e f o r e t r e a tment, and 11.0 cm/year while on treatment.
The two c a s e s represent a new syndrome of dwarfism due t o b i o l o g i c a l l y i n a c t i v e , inmunoreactive GH.
I f erroneously diagnosed a s having Laron Syndrome, t h e s e p a t i e n t s may be denied t h e b e n e f i t of treatment. 9 . 1 225 < 5 71 72 CB-154 s i g n i f i c a n t l y lowered GH and P r c o n c e n t r a t i o n , and i mroved t h e OGTT. While on CB-154 a 24 Urine e x c r e t i o n o f hydroxy r o l i n e f e l l 10 f o l d ; he p e r s p i r e d l e s s , and h i s shoe s i z e and ength did not i n c r e a s e . However, l e f t h e e l pad 
Antibodies t o t h y r o i d cytoplasm (T.C.A.), t o t h y r o i d n u c l e i (ANA) and t o t h y r o g l o b u l i n (T.G.A.) were determined i n 30 c h i l d r e n with t h y m t o x i c o s i e (Tx), i n 1 3 with euthyroid g o i t e r (EG), i n 9 with hypothyroidism and g o i t e r (H.G.) and i n 6 with hypothyroidism w i t h no g o i t e r (H) . H i s t o c o m p a t i b i l i t y (HL-A)
a n t i g e n s were a l s o s t u d i e d . The r e s u l t s ( a s p e r c e n t a g e s ) were: P a t i e n t s T.C.A. T.G.A. ANA -- p <0.05) whereas t h e o t h e r t h y r o i d p a t i e n t s d i d n o t . S i b l i n g s , one w i t h Tx and one with j u v e n i l e d i a b e t e s were %LA i d e n t i c a l (Bet) whereas an unaffected s i b l i n g shared none of t h e types.
Families of Tx had increased Tx, rheumatoid a r t h r i t i s and S.L.E. I n summary. Tx is s t r o n g l y i n h e r i t e d and r e l a t e d t o HLA-BE. P a t i e n t s w i t h B8 have more T.G.A. and higher t i t e r s of T.C.A.. but show l e s s tendency t o r e m i t . W e s p e c u l a t e t h a t Tx :
an antibody mediated d i s e a s e and t h y r o i d i t i s a predominantwcel nediated d i s o r d e r .
Supported by N I H g r a n t s AM19286 and AM05745.
NEUROENDOCRINE EVALUATION OF A PATIENT WITH KEARNS-
Lawr ence-; k o l l e g e and Birth Defects I n s t i t u t e , New York S t a t e Department of Health, Albany, New York.
I In Kearns-Sayre Syndrome (KSS) ( p r o q r e s s i v e e x t e r n a l ophthalmoplegia, pigmentary r e t i n a l degeneration, and h e a r t block) t h e growth f a i l u r e and delayed sexual maturation have not previously been s t u d i e d i n d e t a i l . W e i n v e s t i g a t e d a 155 y e a r o l d boy with KSS. A CAT scan revealed l o s s of t h e basal ganglia and of c e r eb e l l a r white matter. His bone age was 10 y e a r s . An OGTT was abnormal a t 120 and 180 minutes (161 and 164 mg/dl r e s p e c t i v e l y ) .
The IV GTT was normal: K value 2.31. Thyroid f u n c t i o n was normal i n t h e basal s t a t e ; following TRH, t h e TSH and p r o l a c t i n respons e s w e r e n o r m a l , but t h e Tr had not increased by 90 minutes. The growth hormone response was normal t o both i n s u l i n and qlucagon. The plasma c o r t i s o l and ACTH showed normal d i u r n a l v a r i a t i o n ; a f t e r r e l e a s e from metapyrone block, n e i t h e r t h e plasma c o r t i s o l nor t h e 17-OH e x c r e t i o n increased a p p r o p r i a t e l y , although t h e 4CTH response was normal. The LH, FSH and t e s t o s t e r o n e were nor-~1 f o r h i s BA; following t h r e e days of high dose HCG, t h e t e st o s t e r o n e did not i n c r e a s e . A f t e r water d e p r i v a t i o n , t h e u r i n a r y ~s m o l a l i t y was 1011 mosm/kg.
Thus i n our p a t i e n t with KSS t h e r e i s evidence t o suggest l a d 3f f u n c t i o n a l r e s e r v e o r end organ unresponsiveness of t h e thyroid, adrenal and t e s t i s ; hypothalamic-pituitary f u n c t i o n appears :o be i n t a c t t o provocative s t i m u l i .
